XORTX Therapeutics Inc.

XRTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.86

-$0.09 (-4.62%)

At close: Sep 22, 2026, 4:00 PM ET

$1.75

-$0.11 (-5.91%)

After-hours: Sep 22, 2026, 7:35 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $543.05K

Enterprise Value $-458.15K

Beta 0.08

Average Volume 22.8K

Shares Outstanding (Diluted) 1.62M

Shares Change YoY 967.58%

Institutional Ownership 0.00%

Exchange NASDAQ

ISIN CA98420Q4051

Price Performance

Price Change 1M -4.0%

Price Change 3M -7.7%

Price Change 6M 0.5%

Price Change YTD -32.6%

Price Change 1Y -55.9%

Price Change 3Y -93.8%

Price Change 5Y -99.1%

1M CAGR (ann.) -8.4%

1Y CAGR (ann.) -54.6%

5Y CAGR (ann.) -62.0%

All-Time CAGR -37.4%

Valuation

PE Ratio -0.03

Forward PE 0.14

PEG Ratio -0.01

Forward PEG 0.00

PS Ratio N/A

Forward PS 0.00

PB Ratio 0.10

P/FCF Ratio -0.29

P/Adj. FCF Ratio -0.28

P/OCF Ratio -0.62

EV/Sales N/A

EV/EBIT 0.12

EV/EBITDA 0.12

EV/FCF 0.25

Earnings Yield -3369.8%

FCF Yield -349.1%

Adj. FCF Yield -352.3%

Financial Health

Net Cash $992.85K

Total Debt $0

Cash & Short-Term Investments $992.85K

Total Assets $6.18M

Current Ratio 3.59

Quick Ratio 3.59

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -7.20

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -0.9%

Returns

Return on Assets -59.7%

Return on Equity -127.0%

Return on Invested Capital -70.3%

Return on Capital Employed -70.3%

Return on Tangible Assets -101.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -78.7%

EPS CAGR 5Y 20.2%

EPS CAGR 10Y 7.1%

FCF CAGR 3Y 40.9%

FCF CAGR 5Y 38.8%

FCF CAGR 10Y -14.6%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-5M

Free Cash Flow $-1.87M

Adj. Free Cash Flow $-1.88M

FCF Per Share -$1.14

OCF Per Share -$3.09

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-101.96K

Operating Income $-3.86M

EBITDA $-3.76M

Net Income $-3.7M

EPS (Diluted) -$64.70

Revenue / Employee N/A

Profit / Employee $-1.85M

Employees 2